A Multimatrix E-Nose With Optimal Multiranged AFE Circuit for Human Volatilome Fingerprinting
Our bodies continuously produce a unique cocktail of chemicals, known as the "volatilome," which forms a personal scent signature. This chemical fingerprint, released through our breath, blood, urine, and other bodily fluids, provides valuable insights into our health. Alterations in this chemical signature can signal the early onset of disease, making them powerful biomarkers for detecting the transition from health to illness. Traditionally, diagnosing illnesses often relies on methods that are expensive, slow, and sometimes invasive for the patient.
In a promising step toward a new era of diagnostics, researchers have developed sophisticated, affordable, and user-friendly electronic noses (e-noses). These devices use gas sensor arrays to capture human volatilomes, converting them into digital "fingerprints" for disease detection and classification using pattern recognition algorithms.
This study introduces SPYROX, an electronic nose (e-nose) designed to detect and interpret the complex mixture of volatile compounds in biological samples, translating them into digital patterns for analysis using machine learning models.
The SPYROX e-nose is specifically designed as a versatile tool for human health analysis. It integrates an array of eight distinct metal-oxide gas sensors, along with a power module, airflow control system, and mainboard, all housed within a plexiglass enclosure. When molecules from a sample—such as a patient's breath—pass over the sensors, they induce changes in electrical signals. By combining the responses from all eight sensors, the device generates a detailed and distinctive digital fingerprint of the sample's chemical composition.
A key feature in the SPYROX system lies in the simplicity of its analog front-end circuit (AFE): it is based on a common voltage divider that is "driven" by a multi-ranging algorithm to increase the readout sensitivity of the signals. The chemical concentrations can vary dramatically between different types of samples; for instance, exhaled breath contains very diluted compounds compared to the vapor from a liquid biological sample. Owing to its optimized multiranging algorithm, the circuit autonomously adjusts its sensitivity to maintain optimal signal clarity across a wide range of sample types. SPYROX functions as a multimatrix device, uniquely capable of analyzing a diverse range of biological substrates, including exhaled breath as well as vapors emitted from blood and urine.
The SPYROX e-nose's ability to analyze human volatilome fingerprints was evaluated through classification tests using both individual chemical standards and complex gas mixtures. These tests demonstrated high accuracy and a clear distinction between chemical classes.
The goal of this research is to aid clinical diagnosis. By fingerprinting the human volatilome, the SPYROX e-nose offers the potential to detect cancer, chronic respiratory conditions, and metabolic disorders at their earliest stages. Imagine a future where a routine check-up might involve simply breathing into a device to get an instant snapshot of your health. This technology offers the potential to support doctors by providing a rapid, low-cost, user-friendly, and non-invasive method for screening diseases.